Genecraft Inc.
Records under this name other than the patents Genecraft Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 8 of 8 · Back to Genecraft Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,853,366 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Term ended Term ended Feb 12, 2022 · Medium confidence | Term ended | Term ended Feb 12, 2022 | Medium confidence |
| US 9,005,612 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Term ended Term ended Jan 17, 2022 · Medium confidence | Term ended | Term ended Jan 17, 2022 | Medium confidence |
| US 8,197,810 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Lapsed on the fee record Ended Jun 12, 2020 · Low confidence | Lapsed on the fee record | Ended Jun 12, 2020 | Low confidence |
| US 8,188,237 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Lapsed on the fee record Ended May 29, 2020 · High confidence | Lapsed on the fee record | Ended May 29, 2020 | High confidence |
| US 8,147,835 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Lapsed on the fee record Ended Apr 3, 2020 · Low confidence | Lapsed on the fee record | Ended Apr 3, 2020 | Low confidence |
| US 8,106,161 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Lapsed on the fee record Ended Jan 31, 2020 · High confidence | Lapsed on the fee record | Ended Jan 31, 2020 | High confidence |
| US 7,118,751 | DNA vaccines encoding antigen linked to a domain that binds CD40 Formerly held Lapsed on the fee record Ended Oct 10, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 10, 2014 | From the USPTO record |
| US 7,754,208 | Binding Domain-Immunoglobulin Fusion Proteins Formerly held Lapsed on the fee record Ended Jul 13, 2014 · High confidence | Lapsed on the fee record | Ended Jul 13, 2014 | High confidence |